-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics appoints Rich Daly to board of directors

PUBT·09/29/2026 11:03:07
Listen to the news
Aquestive Therapeutics appoints Rich Daly to board of directors
  • Aquestive Therapeutics appointed Rich Daly to its board, effective Oct. 14, 2026.
  • Daly brings more than 30 years of biopharma leadership, including commercial and operating roles at AstraZeneca, Takeda, Catalyst.
  • The board will have eight directors following the appointment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290700PRIMZONEFULLFEED9835487) on September 29, 2026, and is solely responsible for the information contained therein.